Intra-articular corticosteroid clinical trials
Intra-articular corticosteroid is named as an intervention in 2 current clinical trials in our Italy and Turkey registers. 1 is recruiting patients now. The most common phase is Phase 3. The sponsor with the most trials is Istituto Giannina Gaslini (1). The most-studied condition is Oligoarthritis, Juvenile.
Patient leaflets for Intra-articular corticosteroid
The package leaflet is the official guide for patients that comes with every medicine. These links go to the regulators that publish it.
- UKUnited Kingdom: Search MHRA ProductsPatient information leaflets and SmPCs for UK-licensed products.
- USUnited States: Search DailyMedFDA-approved labels, including patient and medication guides.
Leaflets differ between brands and countries; always read the one that comes with your own medicine. This is regulatory information, not medical advice.
Trials by status
Trials by phase
Clinical trials of Intra-articular corticosteroid
2 trials| Study | Phase | Status | Lead sponsor | Registers |
|---|---|---|---|---|
|
STep-up and Step-down Therapeutic Strategies in Childhood ARthritiS
NCT03728478 · ClinicalTrials.gov ↗ · Oligoarthritis, Juvenile, Polyarthritis, Juvenile, Rheumatoid Factor Negative
|
Phase 3 | Recruiting | Istituto Giannina Gaslini | Italy |
|
US-Guided Saphenous Block in Knee OA
NCT07868770 · ClinicalTrials.gov ↗ · Knee Osteoarthritis, Osteoarthritis, Knee, Gonarthrosis
|
Not applicable | Not yet open | Gaziler Physical Medicine and Rehabilitation Education and Research Hospital | Turkey |
Registers list studies that are recruiting, about to open, active but closed to enrolment, or enrolling by invitation. The UK and USA registers cover industry-sponsored studies only. Trial titles and statuses are copied from the registry as published.
Conditions studied with Intra-articular corticosteroid
6 conditionsSponsors
lead sponsor per trial| Lead sponsor | Trials |
|---|---|
| Istituto Giannina Gaslini | 1 |
| Gaziler Physical Medicine and Rehabilitation Education and Research Hospital | 1 |
By country register
| Register | Trials | Recruiting |
|---|---|---|
| Clinical trials in Italy | 1 | 1 |
| Clinical trials in Turkey | 1 | 0 |
A trial with sites in more than one country appears in each of those registers.
Related compounds
Questions about Intra-articular corticosteroid trials
How many clinical trials are testing Intra-articular corticosteroid?
2 current trials in our Italy and Turkey registers name Intra-articular corticosteroid as a drug or biological intervention, as of the registry sync on 11 October 2026. Completed and withdrawn studies are not counted.
Are Intra-articular corticosteroid trials recruiting patients?
Yes. 1 of the 2 trials is recruiting: 1 with sites in Italy. Eligibility and site contacts are on each trial's record. Only the study team can confirm whether a patient is eligible.
Who sponsors Intra-articular corticosteroid clinical trials?
Istituto Giannina Gaslini (1) and Gaziler Physical Medicine and Rehabilitation Education and Research Hospital (1). The number in brackets is how many trials each organisation leads.
Where does this information come from?
Every trial, status, phase and sponsor on this page is copied from public ClinicalTrials.gov records by a daily sync. Nothing here describes how Intra-articular corticosteroid works or whether it is effective, and it is not medical advice.
How this page is built
Everything on this page is copied from public ClinicalTrials.gov registry records — it is not written from memory, and nothing here describes how Intra-articular corticosteroid works or whether it is effective. Each trial links to its own record so you can check it yourself.
- ClinicalTrials.gov (U.S. National Library of Medicine) ↗ Trial IDs, titles, intervention names and synonyms, phase, overall status, lead sponsor and conditions for every trial on this page
This page is built automatically: a daily sync job reads the registry records behind our country trial registers, collects every trial that lists Intra-articular corticosteroid (or a registered synonym) as a drug or biological intervention, and tabulates the registry fields directly. Placebos and generic comparators are excluded. There is no AI drafting and no per-compound editorial pass, and the page has not been clinically reviewed. The “last verified” date above is the timestamp of that sync, not a review date. Our general editorial approach is described in our editorial standards and corrections policy. The ClinicalTrials.gov data on this page was last retrieved on 11 Oct 2026. How every register is built: methodology · fixes we have made: corrections log.